Device Classification Evaluation

Accurately Selecting Device Classification

The main challenge for device classification evaluation lies in the subjectivity and complexity of the FDA regulatory framework. This leads to several hurdles that companies and regulators face:

  • Interpretation of ambiguous criteria
  • Keeping pace with technological advancements
  • Balancing risk and regulatory burden
  • Resource constraints
  • Lack of transparency and consistency

The FDA classification system relies on specific rules and criteria to categorize devices into different classes (I, II, III). However, some key terms and concepts within these rules can be open to interpretation, leading to potential inconsistencies and disagreements between companies and the FDA. We decipher the FDA’s cryptic regulations, demystifying the classification process for complete peace of mind. 

Classification directly impacts the level of premarket requirements a device needs to fulfill. Lower risk class devices generally require less rigorous regulatory controls, while higher risk classifications demand more extensive testing and clinical data. Our seasoned experts draw on extensive experience and a deep understanding of the ever-evolving regulatory landscape to confidently pinpoint the appropriate class of your device.

Manufacturers and regulatory agencies alike, may face limitations in resources dedicated to classification evaluation. This can lead to delays in the review process, especially for newer or more complex devices requiring in-depth assessment. We streamline the process, saving you valuable time and resources to focus on what matters most – bringing your life-changing technology to the world.

Eliminate the guesswork and anxiety. The rationale behind specific classification decisions might not always be fully explained, leading to potential frustration and uncertainty. Additionally, inconsistencies in applying the rules across different devices can raise concerns about fairness and predictability. AlvaMed provides the roadmap you need to navigate the FDA with confidence and avoid costly delays.

We work alongside you every step of the way, providing insightful guidance and proactive support to ensure your classification journey is a success.

AlvaMed cuts through the complexities of FDA device classification, guiding your product to a clear and efficient market path.

Our clients are happy to be references – we are happy to share their contact information when you meet with us.

Ready To Schedule A Call?

We look forward to discussing AlvaMed’s services with you.

Device Classification Evaluation FAQ's

The FDA classifies medical devices into three classes (I, II, and III) based on the level of risk they pose to patients. This risk assessment considers factors like:

  • Intended use: What is the device designed to do? How does it interact with the body?
  • Degree of invasiveness: Is the device implanted, inserted, or used externally?
  • Duration of use: Is the device intended for short-term, long-term, or permanent use?
  • Technological complexity: Does the device incorporate advanced technologies or rely on well-established principles?
  • Available data: Is there existing clinical data to support the safety and effectiveness of the device?

While the 513(g) process doesn’t directly determine a device’s classification, it can be a valuable tool for obtaining information that aids in classification decisions.

Here’s how it works:

  1. Device Manufacturer submits a 513(g) request: You initiate the process by formally asking the FDA for information on the classification and applicable regulatory requirements for your device.
  2. FDA reviews and responds within 60 days: They evaluate your device’s description and intended use, referencing existing classification regulations and guidance documents.
  3. FDA provides a written response: Their response outlines:
    • The device’s classification (if already established).
    • The applicable regulatory requirements.
    • Recommendations for further steps, such as submitting a 510(k) or De Novo request for formal classification.

Remember, the 513(g) response is not a binding classification decision. It’s an informal guidance to help you navigate the process. However, it can be useful for:

  • Confirming a suspected classification: If you’re relatively certain of your device’s class, the 513(g) response can provide reassurance and clarity.
  • Obtaining information for a 510(k) or De Novo submission: The insights from the FDA can guide your preparation for these formal classification pathways.
  • Resolving ambiguities: If you’re unsure about certain regulatory requirements or classification criteria, the FDA’s response can provide clarification.

The classification directly impacts the premarket requirements your device must meet before being marketed. Class I devices generally have the least stringent requirements, while Class III devices require the most extensive testing and clinical data.

  • Class I: General controls only.
  • Class II: General controls and special controls, which may include performance standards, post-market surveillance, and labeling requirements.
  • Class III: Premarket approval (PMA) required, involving significant clinical data and FDA review.

Keira Jessop

Director of Regulatory Affairs

Empower your medical breakthrough with Keira’s expert device classification guidance. We navigate the intricate FDA landscape, ensuring your innovation finds the perfect regulatory fit and paves the way for a swift, compliant market launch.

Schedule a meeting with Keira to see how AlvaMed guide your market path through regulatory approvals.